Core Scientific's $1B Morgan Stanley Loan: A Liquidity Lifeline or a Sign of Strain?

Core Scientific has secured a significant liquidity boost with a $500 million 364-day loan facility from Morgan Stanley. The deal includes an accordion feature that could increase total commitments by up to an additional $500 million, bringing the potential total to $1 billion. Borrowings will carry an interest rate of SOFR plus 250 basis points.

This move directly addresses the company's strained balance sheet. As of September 30, 2025, Core Scientific held $453.4 million in cash against total liabilities of $3.4 billion. The new facility provides a crucial lifeline, offering immediate access to capital for data center development and operations.

Yet the scale of the debt underscores the financial pressure. The company is tapping a massive credit line to fund its core strategy, highlighting a reliance on external financing to manage its substantial obligations.

The Pivot: Execution on the AI Colocation Plan

The company's pivot to AI colocation is now in motion. Core Scientific has energized ~350 MW of power under its landmark $10 billion CoreWeave contract and remains on track to deliver a total of ~590 MW by early 2027. CEO Adam Sullivan stated the firm is "past the halfway point" on existing builds and scaling a 1.5 gigawatt pipeline of leasable capacity. This execution is critical for monetizing the massive power infrastructure the company is developing.

Near-term demand signals are emerging. A major investor, Trip Miller of Gullane Capital Partners, expects Core Scientific to announce greater than 100 MW of new deals in the next 90 days. He projects the company could lease a total of roughly 400 megawatts this year, citing strong demand for AI computing power. This anticipated near-term leasing activity is the critical path to generating revenue from the company's substantial power capacity.

The bottom line is that Core Scientific must now transition from building power to filling it. The execution on the CoreWeave contract demonstrates capability, but the real test is converting its 1 gigawatt of data center capacity and another 1.5 gigawatts of power for expansion into paying customers. The incoming demand signal provides a positive near-term catalyst, but sustained growth depends on consistently leasing this massive pipeline.

The Numbers: Pressure Points and Price Action

The stock's recent path tells a story of volatility and persistent pressure. After hitting a 52-week high of $23.63, shares have pulled back sharply, trading around $15.84. That's a decline of over 30% from its peak, reflecting the market's focus on the company's financial strain. Yet this pullback sits atop a longer-term surge, with the stock having climbed 39.1% over the past year. This divergence highlights a tension between the market's optimism on the AI pivot and its skepticism on the underlying financials.

The core pressure points are clear: persistent net losses and significant debt. The company's balance sheet, as of late 2025, showed $453.4 million in cash against liabilities of $3.4 billion. The new Morgan Stanley facility is a direct response to this imbalance. The stock's volatility, with daily swings often exceeding 5%, is a direct reflection of this high-stakes financial setup. Investors are pricing in both the potential for massive revenue from AI colocation and the risk of further dilution or default if execution falters.

A key institutional signal underscores this caution. In a notable move, hedge fund Paloma Partners drastically reduced its stake, slashing its position from 8.1% to just 0.49% of its reportable U.S. equity assets. This divestment, valued at an estimated $44.41 million, signals a re-evaluation of the capital intensity and operational complexities of the mining sector. For all the promise of the AI pivot, the market is reminding itself that a stock's price action is driven by cash flow, not just contracts.